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Abstract
The differential for an adult patient presenting with necrotic ulcers includes infectious, 
autoimmune, and traumatic etiologies, all of which require thorough history-taking, 
examination, and pathological analysis. Despite the best efforts of clinicians, the 
diagnosis is not always clear, making it vital for providers to maintain an open 
differential. 
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Case
•  58 year-old female with chief complaint of an expanding ulcerative lesion on her left 
lower leg for 1 week since gardening and being pricked by a thorn. The ulcerative 
left leg lesion measured 8x4cm located on the posterior-medial aspect (Figure 1). 
Patient was started on Vancomycin for a suspected cellulitis.
•  Review of past medical history found that she had been hospitalized multiple times 
for similar lesions appearing as dark and pus-filled lesions that would rupture and 
ulcerate. The lesions would envelop her lower legs. These nodules presented after 
minor trauma, such as an insect bite or being pricked by a thorn (as was the case 
most recently while working in her garden). Patient was diagnosed with Buruli ulcers 
in Nairobi, Kenya. 
•  She was treated with surgical debridement and skin grafting, while living in Africa. 
Skin grafting was temporarily effective and the patient was hospitalized repeatedly 
with the same presenting symptoms and, ultimately, the same surgical management. 
Learning Objectives
•  Maintain an open differential in cases that do not immediately have a clear 
diagnosis. 
•  Early biopsy and histologic examination to rule out infectious etiologies is critical to 
guide the diagnosis for pyoderma gangrenosum(PG). 
•  Once a diagnosis of PG is made, management should not be limited to reducing 
ulcerative skin lesions, but must also include consideration for treatment of other 
concurrent systemic diseases.
Course
•  Her symptoms did not improve and dermatology was consulted. Ultimately a wedge 
biopsy was taken from the left lower extremity lesion (Figure 2). 
•  Fungal and mycobacterial cultures (GMS, PAS and Fite stains) returned negative. No 
dramatic improvement was made on antibiotics. Chronic non-healing ulcers with 
inflammatory biopsy and no clear infectious source prompted a consideration of an 
underlying autoimmune process and pointed to pyoderma gangrenosum (PG).
•  The patient was placed on methylprednisone, and this resulted in gradual healing 
of her wounds. She was discharged on steroid therapy with a gradual taper as the 
skin lesions resolved. Notable laboratory findings found during continued outpatient 
workup included elevations in serum M IgG. 
Discussion
•  Pyoderma gangrenosum (PG) is a condition characterized by large, painful ulcers that develop on the skin, specifically 
the lower legs. Rarely an isolated occurrence, PG occurs most often in the setting of a pre-existing autoimmune 
disorder, such as Crohn’s disease, rheumatoid arthritis, or multiple myeloma.
•  The ulcerative lesions are both formed and exacerbated by trauma (even minor).  Treatment with corticosteroids is 
widely considered effective as a means of symptom reduction. Other treatments, however, such as interleukin-1 
inhibitors, have also proven to have promising reduction in disease.
•  The association between monoclonal gammopathies/paraproteinemias and PG has been well-documented in multiple 
case studies. Continued evaluation of the patient presented in this case with a specific focus on a recent serum M 
spike is critical for her general health and prevention of further PG recurrences.
Knowledge Survey
Figure 1: Sequential healing of left lower leg lesion 
from admission to 56 days of therapy.
Figure 2: Left lower leg wedge biopsy shown 
at low and high power views, neutrophilic 
predominance in both epidermal and dermal 
skin layers with neutrophilic microabcesses.
